about
Update on biomarkers for the detection of lung cancer.TIAM1 variants improve clinical outcome in neuroblastoma.Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients.Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLCPhase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)
P50
Q37645219-A47AD74C-6AEB-43CF-A5F8-DA3112F5187AQ38830217-6FED87C0-4512-4655-B1A1-D765EA51AC07Q38875233-9DDAC6BE-67C7-4D48-ACC4-CEF586D27229Q42492427-56C31ECF-E1D8-42C0-BE8E-6A455579C0DCQ42502215-8317A6A8-6EC2-498B-A6E5-A097512004C2Q44197652-702932A4-8015-48AB-A82E-AD2DA4D7A68AQ48685455-5DC2C3A0-D259-4410-A210-06AA8857AA85Q54364360-FC0088D9-BD13-473D-8139-D81AC16184FCQ54391726-159A7277-3C9A-4E66-BF0E-D4660C5D6011Q63441350-3A1CBFFA-DDE3-4591-8329-5926C434E480Q63441355-FD83E365-6C1A-43D4-AA98-84F6E1FB780F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elena Sanmartín
@ast
Elena Sanmartín
@en
Elena Sanmartín
@es
Elena Sanmartín
@nl
Elena Sanmartín
@sl
type
label
Elena Sanmartín
@ast
Elena Sanmartín
@en
Elena Sanmartín
@es
Elena Sanmartín
@nl
Elena Sanmartín
@sl
prefLabel
Elena Sanmartín
@ast
Elena Sanmartín
@en
Elena Sanmartín
@es
Elena Sanmartín
@nl
Elena Sanmartín
@sl
P106
P21
P31
P496
0000-0002-4541-0092